Description
This liquid spray spray presents Bremelanotide (PT-141), a cyclic melanocortin receptor agonist derived from alpha-MSH, as a mucosal-route research preparation.
In cell and animal models, research has addressed melanocortin receptor engagement, centrally mediated behavior, and second-messenger signaling. The liquid spray route is useful for studying central-acting peptide delivery.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.